Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) inhibits insulin signal transduction in a variety of cell backgrounds, which might contribute to peripheral insulin resistance. However, because of the large number of potential phosphorylation sites, the mechanism of inhibition has been difficult to determine. One serine residue located near the phosphotyrosine-binding (PTB) domain in IRS-1 (Ser(307) in rat IRS-1 or Ser(312) in human IRS-1) is phosphorylated via several mechanisms, including insulin-stimulated kinases or stress-activated kinases like JNK1. During a yeast tri-hybrid assay, phosphorylation of Ser(307) by JNK1 disrupted the interaction between the catalytic domain of the insulin receptor and the PTB domain of IRS-1. In 32D myeloid progenitor cells, phosphorylation of Ser(307) inhibited insulin stimulation of the phosphatidylinositol 3-kinase and MAPK cascades. These results suggest that inhibition of PTB domain function in IRS-1 by phosphorylation of Ser(307) (Ser(312) in human IRS-1) might be a general mechanism to regulate insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, phosphorylation of these serine residues impedes the normal association of IRS-1 with the insulin receptor, thereby impairing downstream propagation of insulin signaling (16,19).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationKuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Research works printed but not linked: 6
- Maezono, K., Osman, A., Patti, M. E., Cusi, K., Pendergrass, M., DeFronzo, R. A., and Mandarino, L. (1998) Diabetes 47, 333A (abstr.)
- Carboni, J. M., Yan, N., Cox, A. D., Bustelo, X., Graham, S. M., Lynch, M. J., Weinmann, R., Seizinger, B. R., Der, C. J., Barbacid, M., and Manne, V. (1995) Oncogene 10, 1905-1913
- Myers, M. G., Jr., Wang, L. M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H., and White, M. F. (1994) Mol. Cell. Biol. 14, 3577-3587
- Delahaye, L., Mothe-Satney, I., Myers, M. G., Jr., White, M. F., and Van Obberghen, E. (1998) Endocrinology 139, 4911-4919 · DOI · Paper page
- O'Neill, T. J., Craparo, A., and Gustafson, T. A. (1994) Mol. Cell. Biol. 14, 6433-6442
- Chin, J. E., Liu, F., and Roth, R. A. (1994) Mol. Endocrinol. 8, 51-58
Cited by
Items 601–700 of 999
Maternal chromium restriction induces insulin resistance in adult mice offspring through miRNA
Zhang, Q., Sun, X., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, Z., Qi, C., Wang, T., et al. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3328 · Cited by 24
“The IRS-1/PI3K/Akt axis has an important role in the insulin receptor signaling pathway through cascade phosphorylation (43,44).”
Maternal apical periodontitis is associated with insulin resistance in adult offspring
Tsosura, T. V. S., Chiba, F. Y., Mattera, M. S. D. L. C., Pereira, R. F., Cintra, L. T. Â., Conti, L. C., dos Santos, R. M., Mateus, J., Garbin, C. A. S., & Sumida, D. H. (2019) · International Endodontic Journal · doi:10.1111/iej.13096 · Cited by 25
FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment
Smerieri, A., Montanini, L., Maiuri, L., Bernasconi, S., & Street, M. E. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018000 · Cited by 23
“Total and activated IRS1 contents were similar in both cell lines which did not suggest any significant change in insulin signaling in the two conditions at this level. p85α PI3Kinase content was lower in baseline conditions in the CF cells, corresponding to the fasting state of an in vivo study.”
InfluentialAnalysis of insulin receptor substrate signaling dynamics on microstructured surfaces
Lanzerstorfer, P., Yoneyama, Y., Hakuno, F., Müller, U. C., Höglinger, O., Takahashi, S., & Weghuber, J. (2015) · FEBS Journal · doi:10.1111/febs.13213 · Cited by 22
Franco, N. D. S., Lubaczeuski, C., Guizoni, D. M., Victorio, J. A., Santos-Silva, J. C., Brum, P. C., Carneiro, E. M., & Davel, A. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.018 · Cited by 27
Grunewald, Z. I., Lee, S., Kirkland, R. A., Ross, M. K., & Serre, C. B. D. L. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.11.035 · Cited by 21
Batty, I. H., Fleming, I. N., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20031700 · Cited by 22
Huang, W., Bansode, R. R., Xie, Y., Rowland, L. A., Mehta, M., Davidson, N., & Mehta, K. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250282 · Cited by 20
Su, K., & Dai, C. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2291-1 · Cited by 23
“b In insulin-resistant cells, activated IKKb and JNK, owing to lipid overload, inflammation, and oxidative stress, markedly phosphorylate IRS-1/2, causing their dissociation from IR and proteasomal degradation [203, 204].”
BackgroundAdochio, R., Leitner, J. W., Hedlund, R., & Draznin, B. (2008) · Endocrinology · doi:10.1210/en.2008-0437 · Cited by 22
Liu, G., Zhao, H., Liu, B., Xin, Z., Liu, M., Kosogof, C., Szczepankiewicz, B. G., Wang, S., Clampit, J. E., Gum, R. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.097 · Cited by 24
Kim, B., van Golen, C. M., & Feldman, E. L. (2005) · Endocrinology · doi:10.1210/en.2005-0356 · Cited by 21
Sex-specific differences in hepatic steatosis in obese spontaneously hypertensive (SHROB) rats
Dong, Q., Kuefner, M., Deng, X., Bridges, D., Park, E. A., Elam, M. B., & Raghow, R. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0202-x · Cited by 20
Ma, M.-M., Jin, C., Huang, X., Sun, L., Zhou, H., Wen, X., Huang, X., Du, J.-Y., Sun, H., Ren, Z., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0229-5 · Cited by 20
Type 2 diabetes and atherosclerosis
Donnelly, R., & Davis, K. R. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00019.x · Cited by 22
PM2.5 promotes β cell damage by increasing inflammatory factors in mice with streptozotocin
Zhang, B., Yin, R., Lang, J., Yang, L., Zhao, D., & Ma, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10264 · Cited by 19
“IL-1β downregulates insulin substrate receptor-1 (IRS-1) expression in adipocytes and hepatocytes (19,20), whereas TNFα induces JNK phosphorylation that phosphorylates IRS-1 at Ser307 (53,54).”
BackgroundJMJD8 Is a Novel Molecular Nexus Between Adipocyte-Intrinsic Inflammation and Insulin Resistance
You, D., Jung, B. C., Villivalam, S. D., Lim, H., & Kang, S. (2021) · Diabetes · doi:10.2337/db21-0596 · Cited by 18
Seicaru, E. M., Ilie, I. R. P., Cătinean, A., Craciun, A. M., & Ghervan, C. (2022) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4248 · Cited by 23
Kimani, C. N., Reuter, H., Kotzé, S. H., & Muller, C. J. F. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080392 · Cited by 24
“Furthermore, Akt activity can also be inhibited by JNK, which phosphorylates IRS1 on Ser307, thereby decreasing the interaction between IRS1 and the insulin receptor (IR) [94].”
BackgroundDownregulation of Grb2 contributes to the insulin-sensitizing effect of calorie restriction
Liu, X., Liu, M., Zhang, J., Bai, X. S., Ramos, F. J., Remmen, H. V., Richardson, A. G., Liu, F., Dong, L., & Liu, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90714.2008 · Cited by 20
“Several serine kinases such as the JNK (1, 25), IKK (17), and PKC- (18, 39) have been found to negatively regulate insulinstimulated PI3K signaling by serine phosphorylation of IRS1/2.”
BackgroundInflammation, diet, and type 2 diabetes: a mini-review
Jafaripour, S., Sedighi, S., Jokar, M. H., Aghaei, M., & Moradzadeh, M. (2020) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1750423 · Cited by 23
“Consequently, activation of these signaling pathways and IR creates an impaired loop.([37]) Hyperglycemia induces endothelium and macrophages to produce more IL-6 and increases the production of suppressors of cytokine signaling (SOCS) proteins.”
BackgroundPeng, C., Yang, Y., Chan, K., Wang, C., Chen, M.-L., & Huang, C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024092 · Cited by 19
Sensing the insulin signaling pathway with an antibody array
He, H., Zong, Y., Bernier, M., & Wang, L. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900020 · Cited by 19
“Serine/threonine phosphorylation on IRS proteins results in the inhibition of the insulin signal cascade [12, 19], and the phosphorylation of IRS-1 on serine-307 correlates with impairment in insulin signaling in animal models with type 2 diabetes [20–22].”
BackgroundResultInfluentialEndotoxin-induced alterations of adipose tissue function: a pathway to bovine metabolic stress
Chirivi, M., & Contreras, G. A. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01013-8 · Cited by 21
“IRS1 phosphorylation at serine 307 can impede downstream signaling [178].”
BackgroundThe therapeutic potential of GPR43: a novel role in modulating metabolic health
Cornall, L. M., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1419-9 · Cited by 22
Contreras-Zentella, M. L., & Hernández-Muñoz, R. E. (2021) · Antioxidants · doi:10.3390/antiox10111729 · Cited by 20
“Furthermore, if IRSs are phosphorylated at particular sites, like serine 307, by some kinases such as IKKβ/NF-κB and c-Jun N-terminal kinase (JNK), their signaling activity in this via is reduced and insulin resistance occurs [55].”
BackgroundParray, H. A., & Yun, J. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714441 · Cited by 19
“The JNK pathway is involved in the development of obesity and diabetes [47,48].”
BackgroundThiruppathi, M., Palaniappan, M., Srinivasan, C., & Balasubramanian, K. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0737-1 · Cited by 19
Exercise ameliorates insulin resistance and improves ASK1‐mediated insulin signalling in obese rats
Zhang, Y., Ye, T., Zhou, P., Li, R., Liu, Z., Xie, J., Hua, T., & Sun, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16994 · Cited by 22
de León‐Guerrero, S. D., Salazar‐León, J., Meza‐Sosa, K. F., Valle‐García, D., Aguilar‐León, D., Pedraza‐Alva, G., & Pérez‐Martínez, L. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.048936 · Cited by 25
“In addition, inflammatory signaling, mediated by cytokines or pattern recognition receptors, activate JNK and IKK kinases, which regulate insulin resistance by phosphorylating IRS, which prevents its activation by the insulin receptor (Aguirre et al., 2002; Gao et al., 2002).”
Johnson, D. R., O’Connor, J. C., Satpathy, A. T., & Freund, G. G. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74017-1 · Cited by 26
Chen, X.-L., Xia, Z., Ben, D., & Wei, D. (2010) · Burns · doi:10.1016/j.burns.2010.04.005 · Cited by 19
“The experiment in cells revealed the mechanism by which serine hyperphosphorylation inhibits IRS-1 tyrosine phosphorylation [14].”
BackgroundResetting the Aging Clock: Implications for Managing Age-Related Diseases
Nobrega, A. K. D., Luz, K. V., & Lyons, L. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_9 · Cited by 21
Harte, A. L., Tripathi, G., Piya, M. K., Barber, T. M., Clapham, J. C., Al‐Daghri, N. M., Aldisi, D. A., Kumsaiyai, W., Saravanan, P., Fowler, A. E., et al. (2013) · Obesity · doi:10.1002/oby.20336 · Cited by 27
“Previous studies have implicated both NFjB and JNK inflammatory pathways as potential therapeutic molecular targets for the treatment of obesity mediated insulin resistance and T2DM (7,8,10,17-19).”
BackgroundEraky, S. M., Ramadan, N. M., & El‐Magd, N. F. A. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3678 · Cited by 19
Ye, Z., Liang, R., Wang, B., Yu, L., Liu, W., Wang, X., Xiao, L., Ma, J., Zhou, M., & Chen, W. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120331 · Cited by 19
Chen, Y., Jiang, Y., Cui, T., Hou, L., Zhao, R., Bo, S., Zou, L., & Yin, C. (2023) · Biochimie · doi:10.1016/j.biochi.2023.02.004 · Cited by 22
Ismail, W. I. W., King, J. A., Anwar, K., & Pillay, T. S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24513 · Cited by 17
“This phosphorylation blocks interactions with the insulin receptor b-subunit, decreases tyrosine phosphorylation, and inhibits insulin action in the cells [Aguirre et al., 2002; Gao et al., 2003].”
BackgroundZhou, X., Ren, L., Yu, Z., Huang, X., Li, Y., & Wang, C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.023 · Cited by 17
Muñoz, V. R., Gaspar, R. C., Kuga, G. K., Pavan, I. C. B., Simabuco, F. M., da Silva, A. S. R., de Moura, L. P., Cintra, D. E., Ropelle, E. R., & Pauli, J. R. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly293 · Cited by 18
Dungan, C. M., Gordon, B. S., & Williamson, D. L. (2019) · Physiological Reports · doi:10.14814/phy2.14011 · Cited by 17
“Consistent with the rationale that acute treadmill exercise inhibits mTORC1 signaling and improves insulin-stimulated signaling activation, nonexercised REDD1 KO mice exhibited lower within animal noninsulin-to-insulinstimulated percent change in skeletal muscle 4E-BP1 (P = 0.06) and S6K1 (P 0.05) phosphorylation when…”
BackgroundInfluentialPerry, B. W., Andrew, A. L., Kamal, A. H. M., Card, D. C., Schield, D. R., Pasquesi, G. I. M., Pellegrino, M. W., Mackessy, S. P., Chowdhury, S. M., Secor, S. M., et al. (2019) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2019.0910 · Cited by 16
El‐Daly, S. M., Medhat, D., El‐Bana, M. A., Abdel‐Latif, Y., El‐Naggar, M. E., Omara, E. A. A., Morsy, S., & Hussein, J. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106566 · Cited by 18
Blood glucose regulation in context of infection
Wensveen, F. M., Šestan, M., Wensveen, T. T., & Polić, B. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.06.009 · Cited by 22
Hitomi, H., Mehta, P. K., Taniyama, Y., Lassegue, B. P., Seidel-Rogol, B. L., Martín, A. S., & Griendling, K. K. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00017.2011 · Cited by 19
“JNK stimulates phosphorylation on IRS-1 Ser307 by insulin and negatively impacts insulin signaling (1, 2).”
BackgroundRNF186 impairs insulin sensitivity by inducing ER stress in mouse primary hepatocytes
Tong, X., Zhang, Q., Wang, L., Ji, Y., Zhang, L., Xie, L., Chen, W., & Zhang, H. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.09.008 · Cited by 19
Jessen, N., Buhl, E. S., Schmitz, O., & Lund, S. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.035 · Cited by 18
Alvarez, B., Stroeken, P. J. M., Edel, M. J., & Roos, E. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21215 · Cited by 20
“L I S S , I N C . many protein–protein interactions involved in signaling, for example of Shc and IRS-1 (Aguirre et al., 2002; Carloni et al., 2004).”
BackgroundMeltzer, M., Long, K. K., Nie, Y., Gupta, M., Yang, J.-H., & Montano, M. A. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00199.x · Cited by 17
“Inflammatory stress is an antagonist of anabolic IGF-1 signaling, in part through i) blocking downstream activation of pro-anabolic phospho-Akt levels thereby reducing protein synthesis (Aguirre et al., 2002; Strle et al., 2006), and ii) through stimulation of catabolic pathways, namely p38 MAPK and NF-κB mediated act…”
BackgroundMingo-Sion, A. M., Ferguson, H. A., Koller, E., Reyland, M. E., & Berg, C. L. V. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-0669-0 · Cited by 17
“Others have reported that IRS-1 tyrosine phosphorylation is inhibited following IRS-1 Ser(312) phosphorylation, suggesting that serine 312 negatively regulates insulin and IGF-I signaling [13,17,24].”
BackgroundResultClinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers
Liu, C., Chen, H., Ma, Y., Zhang, L., Chen, L., Huang, J., Zhao, Z., Jiang, H., & Kong, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501305 · Cited by 31
Buonanno, S., Gaggiano, C., Terribili, R., Cantarini, L., Frediani, B., & Gentileschi, S. (2025) · Inflammation Research · doi:10.1007/s00011-025-02140-2 · Cited by 23
“In particular, TNF exacerbates insulin resistance by inhibiting insulin receptor phosphory - lation and GLUT4 translocation [ 62 ].”
Wang, T., Zuo, G., Yao, L., Yuan, C., Li, H., Lai, Y., Chen, Z., Zhang, J., Jin, Y., Yamahara, J., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10901 · Cited by 19
Pan, J., Yin, J., Gan, L., & Xue, J. (2022) · Obesity Reviews · doi:10.1111/obr.13521 · Cited by 23
“between insulin receptor and IRS-1, ultimately preventing insulin signaling.(157) Second, increased β-cell-deleterious and insulindesensitizing adipokines (IL-1β, leptin, and resistin) and decreased β-cell-protective and insulin-sensitizing adipokines (adiponectin and visfatin) were observed in individuals with obesit…”
BackgroundZorina, I. I., Avrova, N. F., Zakharova, I. O., & Shpakov, A. O. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923030070 · Cited by 18
“Phosphorylation of IRS-1 and IRS-2 at Ser and Thr residues by c-Jun N-terminal kinase 1 (JNK1) results in their inactivation, which may be one of the causes of the peripheral and central insulin resistance [16].”
BackgroundCurrent progression in application of extracellular vesicles in central nervous system diseases
Zhang, X., Huang, J., Ni, X.-Y., Zhu, H.-R., Huang, Z., Ding, S., Yang, X., Tan, Y.-D., Chen, J., & Cai, J. (2024) · European journal of medical research · doi:10.1186/s40001-023-01606-5 · Cited by 17
“The main molecular mechanism may be the accumulation of insulin receptor substrate-1 in EVs leading to reduced insulin receptor binding sensitivity and disruption of insulin signaling [152, 153].”
BackgroundAlnaeeli, M., & Noguchi, C. T. (2015) · Adipocyte · doi:10.4161/21623945.2014.978654 · Cited by 16
“During inflammation, cytokines such as TNF-a can block insulin receptor signaling via mechanisms that range from reduced activity of Akt, JNK-mediated activation of insulin receptor substrate serine phosphorylation, to the direct degradation of insulin receptor substrate.(28,29) Not surprisingly, the inhibition of ML…”
BackgroundKadiiska, M. B., Bonini, M. G., Ruggiero, C., Cleland, E., Wicks, S. E., & Stadler, K. (2012) · Diabetes · doi:10.2337/db11-1091 · Cited by 18
“Evidence indicates that any impairment related to insulin signaling proteins, including the phosphorylation of Ser instead of Tyr on the insulin receptor (IR) and IR substrates (IRSs) (5,6), contributes to the development of insulin resistance.”
BackgroundDas, G. C., & Hollinger, F. B. (2012) · Virology · doi:10.1016/j.virol.2012.07.003 · Cited by 16
PKC alpha-dependent regulation of the IGF1 receptor in adult and embryonic rat cardiomyocytes
Maniar, R., Pecherskaya, A., Ila, R., & Solem, M. L. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-7264-x · Cited by 16
“Future experiments will determine if there is a direct role for PKC alpha–dependent regulation of Erk1/Erk2 activity, possibly through interactions with IRS-1 and the IGF1 receptor.”
BackgroundInfluentialLei, H., Lu, F., Dong, H., Xu, L., Wang, J., Zhao, Y., & Huang, Z. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0249-y · Cited by 17
“It has been shown that Ser307 phosphorylation contributes to IRS-1 degradation in hepatocytes in response to insulin [ 32 ] . Ser307 of IRS-1 can be phosphorylated by JNK [33] and the phosphorylation of JNK at the activation loop is essential for activation of the catalytic activity of JNK.”
Background3D-QSAR and docking studies of aminopyridine carboxamide inhibitors of c-Jun N-terminal kinase-1
Yi, P., & Qiu, M. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.04.020 · Cited by 17
Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians
Afsar, B., Afsar, R. E., Caliskan, Y., Lentine, K. L., & Edwards, J. C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05043-8 · Cited by 15
“Inflammation also causes insulin resistance, and it is shown that TNF-α stimulates phosphorylation of IRS-1ser307, leading to suppression of insulin/IGF-1 signaling [35, 36].”
Buscema, M., Grossi, E., Montanini, L., & Street, M. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126020 · Cited by 15
Wang, C., Chen, H., Chan, D., Chiu, C., Liu, S., & Lan, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137228 · Cited by 16
“Phosphorylation of IRS1 Ser307 has been shown to inhibit the interaction between IRS1 and insulin receptor, leading to inhibit insulin action in a 32D myeloid progenitor cell model [30].”
BackgroundN-Acetylcysteine Enhances the Recovery of Ischemic Limb in Type-2 Diabetic Mice
Zhu, Q., Liu, X., Zhu, Q., Liu, Z., Yang, C., Wu, H., Zhang, L., Xia, X., Wang, M., Hao, H., et al. (2022) · Antioxidants · doi:10.3390/antiox11061097 · Cited by 17
“man Ser312) results in its dissociation from the insulin receptor, and also impairs insulin downstream signaling [57,58].”
BackgroundDoes omethoate have the potential to cause insulin resistance?
Zhang, Y., Ren, M., Li, J., Wei, Q., Ren, Z., Lv, J., Niu, F., & Ren, S. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.11.030 · Cited by 16
Sánchez‐Sarasúa, S., Ribes‐Navarro, A., Beltrán-Bretones, M. T., & Sánchez‐Pérez, A. M. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02155-x · Cited by 16
Ziada, D. H., Saadany, S. A. E., Enaba, M., Ghazy, M., & Hasan, A. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/291457 · Cited by 15
“In addition to interleukin (IL)-6 and free fatty acids, cellular stress can induce IR by activating serine phosphorylation of IRS-1, thereby inhibiting its function (11).”
BackgroundDownregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells
Zhang, H., Hoff, H. B., & Sell, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00286-6 · Cited by 15
Gorgani‐Firuzjaee, S., Ahmadi, S., & Meshkani, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.006 · Cited by 16
Signalling Networks Governing Metabolic Inflammation
Dali‐Youcef, N., & Ricci, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_4 · Cited by 14
Jovanović, L., Pantelić, M., Prodanović, R., Vujanac, I., Đurić, M., Tepavčević, S., Vranješ‐Đurić, S., Korićanac, G., & Kirovski, D. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1007-1 · Cited by 14
Kashyap, B., Barge, S., Bharadwaj, S., Deka, B., Rahman, S., Ghosh, A., Manna, P., Dutta, P. P., Sheikh, Y., Kandimalla, R., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153761 · Cited by 15
Some mechanisms of inflammation development in type 2 diabetes mellitus
Бочкарева, Л. А., Недосугова, Л. В., Petunina, N. A., Эдуардовна, Т. М., & Валерьевна, Г. Е. (2021) · Diabetes Mellitus · doi:10.14341/dm12746 · Cited by 18
Pettit‐Mee, R. J., Power, G. J., Cabral-Amador, F. J., Ramirez‐Perez, F. I., Soares, R. N., Sharma, N., Liu, Y., Christou, D. D., Kanaley, J. A., Martinez‐Lemus, L. A., et al. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00006.2022 · Cited by 14
Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2
Soliman, H., Varela, J. N., Nyamandi, V., García-Patiño, M., Lin, G., Bankar, G. R., Jia, Z., & MacLeod, K. M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.89 · Cited by 15
Becattini, B., Zani, F., Breasson, L., Sardi, C., D’Agostino, V., Choo, M., Provenzani, A., Park, J. M., & Solinas, G. (2016) · The FASEB Journal · doi:10.1096/fj.201600393r · Cited by 15
“JNK1 was initially believed to promote insulin resistance by direct phosphorylation of the insulin receptor substrates (7, 8, 10, 12).”
BackgroundDevelopment and Discovery Avenues in Bioactive Natural Products for Glycemic Novel Therapeutics
Suresh Ramnath, N. A. I. K., & Kokil, G. R. (2013) · Studies in natural products chemistry · doi:10.1016/b978-0-444-62615-8.00012-6 · Cited by 23
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 19
[Obesity, inflammation and diabetes].
Miranda-Garduño, L. M., & Reza‐Albarrán, A. (2008) · PubMed · Cited by 14
Prediction of functional phosphorylation sites by incorporating evolutionary information
Niu, S., Wang, Z., Ge, D., Zhang, G., & Li, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2048-z · Cited by 14
Andrews, M., & Arredondo, M. (2012) · BioMetals · doi:10.1007/s10534-012-9543-9 · Cited by 16
The strategic involvement of IRS in cancer progression
Ahmed, M. A., Biswas, T., & Mondal, S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.09.036 · Cited by 14
The Evolving Role of Macrophage Metabolic Reprogramming in Obesity
Makassy, D., Williams, K., & Karwi, Q. G. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.04.017 · Cited by 17
Street, M. E., Buscema, M., Smerieri, A., Montanini, L., & Grossi, E. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.003 · Cited by 15
“, 2002), and interesting molecular mechanisms of insulin-resistance have been shown (Ozes et al., 2001; Klover et al., 2003; Li et al., 2010; Aguirre et al., 2002).”
BackgroundObesity in Gynecologic Oncology
KÖLBL, H., & Bartl, T. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1124-7139 · Cited by 16
“In the context of the chronic increase in lipolysis associated with obesity, elevated free fatty acid concentrations have been found to suppress insulin signaling pathways [11,12].”
BackgroundMolecular Mechanisms of Insulin Resistance
Draznin, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_4 · Cited by 15
Melo, A. M., Bittencourt, P., Nakutis, F. S., Silva, A. P., Cursino, J., dos Santos, G. A., Ashino, N. G., Velloso, L. A., Torsoni, A. S., & Torsoni, M. A. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011105 · Cited by 18
The Mechanisms of Insulin Action
White, M. F., & Copps, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00033-0 · Cited by 13
Self-citationDiabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
Ahmad, R., Chowdhury, K., Kumar, S., Irfan, M., Reddy, G. S., Akter, F., Jahan, D., & Haque, M. (2022) · Biology · doi:10.3390/biology11030382 · Cited by 17
Sobhon, P., Savedvanich, G., & Weerakiet, S. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00124 · Cited by 13
Melloni, M., Sergi, D., Simioni, C., Passaro, A., & Neri, L. M. (2023) · Biology · doi:10.3390/biology12030449 · Cited by 14
“The phosphorylation of IRS1 on serine residues by JNK and MAPK [47,51,52] also hampers its phosphorylation on tyrosine residues making it more susceptible to proteasome-mediated degradation [49,53].”
BackgroundAumueller, E., Remely, M., Baeck, H., Hippe, B., Brath, H., & Haslberger, A. G. (2015) · Lifestyle Genomics · doi:10.1159/000381714 · Cited by 15
Kim, S. S., & Son, S. M. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.5.389 · Cited by 12
Wu‐Mei‐Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells
Yang, X., Li, L., Fang, K., Dong, R., Li, J., Zhao, Y., Dong, H., Yi, P., Huang, Z., Chen, G., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/7283241 · Cited by 13
“This also leads to degradation of IRS-1 and inhibits insulin signaling [22].”
BackgroundRole of free fatty acids on insulin resistance
Vázquez-Jiménez, J. G., Roura-Guiberna, A., Jiménez-Mena, L. R., & Olivares-Reyes, J. A. (2023) · Gaceta Médica de México · doi:10.24875/gmm.m18000092 · Cited by 16
Ha, J. S., Kang, J. Y., Kang, J. E., Park, S. K., Kim, J. M., Kim, C. W., Oh, S.-I., Lee, U., Kim, D., & Heo, H. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-62810-5 · Cited by 14
Liu, Y., Hu, X., Zheng, W. L., Zhang, L., Gui, L., Liang, G., Zhang, Y., Hu, L., Li, X., Zhong, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011608 · Cited by 14
Hu, C., Su, Q., Li, F., Zhang, G., Sun, D., Han, H., Liu, S., & Hu, S. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1230-1 · Cited by 13
Metadata
- Authors
- Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1531-1537
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972590376
- Cited by
- 1,010
- References
- 55
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 30 · 2019: 43 · 2018: 41 · 2017: 33 · 2016: 40 · 2015: 36 · 2014: 57 · 2013: 45 · 2012: 58
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- IRS-1, insulin resistance, insulin signaling, phosphotyrosine binding domain, insulin receptor, JNK1, MAPK signaling, phosphatidylinositol 3-kinase, protein-protein interaction inhibition
- MeSH terms
- Animals, Anisomycin, Anti-Bacterial Agents, Cell Line, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, Phosphatidylinositol 3-Kinases, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.